AKT1 and neoplasm: In contrast, lapatinib exerted profound suppression on SKBR3-pool2 tumor growth (Fig. 2A), and there was no increase in p-Akt levels in the SKBR3-pool2 tumors of lapatinib-treated mice as compared to controls (Fig. 5B left).